Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Regeneron Pharmaceuticals (REGN) Q1 2023 Earnings
REGN
3
Feb
Confirmed
Q2 2022
Q3 2022
Q4 2022
Q1 2023
8.57
9.9
11.23
12.56
Details
Expected EPS
10.44
Actual EPS
12.56
Surprise EPS
2.12
Surprise Percent
+20.31%
Description
Regeneron Pharmaceuticals (REGN) has reported earnings of 12.56 per share for Q1 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login